Post-traumatic stress disorder (PTSD) is a condition with limited effective therapeutic options to date, where 5-HT2A receptor agonists show promise for enhancing cortical plasticity in the brain and ...

(NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced updated efficacy and safety results from the ...

For decades, scientists have investigated the neurokinin-1 receptor (NK1R) as a potential target for treating major depressive disorder. Early studies suggested promise, but enthusiasm faded after ...

Cannabidiol (CBD) could become a therapeutic tool to address some of the most frequent and disabling consequences of fetal ...

Cannabidiol (CBD) could become a therapeutic tool to address some of the most frequent and disabling consequences of fetal ...

Levodopa may reduce the risk of progressing from early to neovascular age-related macular degeneration by targeting GPR143 ...

Federal regulators are telling drugmakers to remove label warnings about potential suicidal thoughts and behaviors from their ...

LMNT reports that GLP-1 medications for obesity and diabetes may lead to electrolyte imbalances, highlighting hydration ...

In April 2025, CMG Pharmaceutical, a subsidiary of CHA Biotech, secured FDA approval for Mezofy (formerly Depipzo), an oral ...

TORONTO - Before Brenda Rogers started taking Ozempic in the spring of 2023, she didn't realize how much "food noise" was sapping her mental energy.

We are very pleased to nominate AMX0318 as a development candidate and were highly impressed by Gubra’s proprietary and ...